Exact Therapeutics AS (OSL:EXTX) Interest Expense : kr-0.09 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Exact Therapeutics AS's interest expense for the six months ended in Dec. 2023 was kr 0.98 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Exact Therapeutics AS's Operating Income for the six months ended in Dec. 2023 was kr -26.13 Mil. Exact Therapeutics AS's Interest Expense for the six months ended in Dec. 2023 was kr 0.98 Mil. Exact Therapeutics AS did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Exact Therapeutics AS Interest Expense Historical Data

The historical data trend for Exact Therapeutics AS's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Interest Expense Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

-0.10

-0.09

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial						0.21	-0.73	0.63	-1.07	0.98

Exact Therapeutics AS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.09 Mil.

Exact Therapeutics AS (OSL:EXTX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Exact Therapeutics AS's Interest Expense for the six months ended in Dec. 2023 was kr0.98 Mil. Its Operating Income for the six months ended in Dec. 2023 was kr-26.13 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was kr0.65 Mil.

Exact Therapeutics AS's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines